Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unipex is a French specialty ingredients distributor and solutions provider serving pharmaceutical, nutraceutical, personal care, and related life science markets. Historically, the company developed, sourced, formulated, and distributed active ingredients, excipients, APIs, nutraceutical ingredients, and specialty chemicals, supported by formulation labs and logistics capabilities in France and nearby regions. Barentz announced the acquisition of Unipex in March 2022, and Unipex Solutions France was fully rebranded as Barentz France in November 2024. As a result, the original Unipex business remains commercially active through Barentz France rather than as an independent standalone company. The business is not a therapeutic drug developer and does not appear to operate a clinical pipeline; its value proposition is ingredient distribution, technical support, sourcing, and application expertise for manufacturers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unipex.